SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

GUIDOBONI, Massimo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.506
AS - Asia 2.401
EU - Europa 843
SA - Sud America 369
Continente sconosciuto - Info sul continente non disponibili 147
AF - Africa 67
OC - Oceania 3
Totale 6.336
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.377
SG - Singapore 965
CN - Cina 424
IT - Italia 353
BD - Bangladesh 279
BR - Brasile 270
VN - Vietnam 238
HK - Hong Kong 213
FI - Finlandia 96
DE - Germania 88
IN - India 63
CA - Canada 59
FR - Francia 52
GB - Regno Unito 51
ID - Indonesia 51
UA - Ucraina 48
MX - Messico 45
RU - Federazione Russa 42
AR - Argentina 39
JP - Giappone 39
ZA - Sudafrica 28
NL - Olanda 22
IQ - Iraq 20
EC - Ecuador 18
AT - Austria 17
TR - Turchia 17
PH - Filippine 16
PL - Polonia 16
CO - Colombia 12
ES - Italia 12
SE - Svezia 12
MA - Marocco 9
KE - Kenya 8
LT - Lituania 8
PK - Pakistan 8
SA - Arabia Saudita 8
UZ - Uzbekistan 8
VE - Venezuela 8
MY - Malesia 7
PY - Paraguay 7
AE - Emirati Arabi Uniti 6
CL - Cile 6
JO - Giordania 6
CR - Costa Rica 5
EG - Egitto 5
NP - Nepal 5
BA - Bosnia-Erzegovina 4
CH - Svizzera 4
HN - Honduras 4
PS - Palestinian Territory 4
UY - Uruguay 4
GR - Grecia 3
IL - Israele 3
JM - Giamaica 3
KG - Kirghizistan 3
PE - Perù 3
TN - Tunisia 3
AL - Albania 2
AU - Australia 2
BE - Belgio 2
BH - Bahrain 2
BO - Bolivia 2
BS - Bahamas 2
CI - Costa d'Avorio 2
DZ - Algeria 2
ET - Etiopia 2
IE - Irlanda 2
KH - Cambogia 2
MN - Mongolia 2
NI - Nicaragua 2
PA - Panama 2
RS - Serbia 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
BY - Bielorussia 1
CG - Congo 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GE - Georgia 1
GN - Guinea 1
GP - Guadalupe 1
KI - Kiribati 1
KY - Cayman, isole 1
KZ - Kazakistan 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
MU - Mauritius 1
MV - Maldive 1
NG - Nigeria 1
PR - Porto Rico 1
PT - Portogallo 1
RO - Romania 1
SC - Seychelles 1
Totale 6.184
Salva come PNG Salva come JPEG
Città #
Singapore 579
San Jose 435
Ashburn 349
Santa Clara 303
Hong Kong 209
Beijing 119
Council Bluffs 115
Ho Chi Minh City 86
Helsinki 85
Los Angeles 83
New York 75
Hanoi 53
Houston 45
Dallas 43
Milan 41
Jakarta 40
Tokyo 39
Woodbridge 37
Chicago 36
Fairfield 36
Jacksonville 31
São Paulo 29
Lauterbourg 28
Mexico City 28
Bologna 26
Toronto 24
Buffalo 23
Ferrara 23
Nuremberg 23
Hefei 22
Rome 22
Shanghai 22
Orem 21
Dearborn 16
Seattle 16
Atlanta 14
Brooklyn 14
London 14
Warsaw 14
Baghdad 12
Da Nang 12
Frankfurt am Main 12
San Francisco 12
Chennai 11
Johannesburg 11
Montreal 11
Phoenix 11
Portland 11
Cambridge 10
Chandler 10
Falkenstein 10
Naples 10
Wilmington 10
Haiphong 9
Curitiba 8
Rio de Janeiro 8
Avon 7
Boardman 7
Guangzhou 7
Manchester 7
Newark 7
Tashkent 7
The Dalles 7
Vienna 7
Amsterdam 6
Boston 6
Denver 6
Guayaquil 6
Hải Dương 6
Izmir 6
Mumbai 6
Nanjing 6
Quito 6
Salt Lake City 6
San Diego 6
Stockholm 6
Amman 5
Biên Hòa 5
Charlotte 5
Figino 5
Guarulhos 5
Lappeenranta 5
Manila 5
Nairobi 5
Nanchang 5
New Delhi 5
Parma 5
Poplar 5
Princeton 5
Ann Arbor 4
Assago 4
Asunción 4
Belo Horizonte 4
Brescia 4
Forlì 4
Montevideo 4
Monza 4
Moscow 4
Munich 4
North Bergen 4
Totale 3.633
Salva come PNG Salva come JPEG
Nome #
The long-term prognostic impact of sentinel lymph node biopsy in patients with primary cutaneous melanoma: a prospective study with 10-year follow-up 198
ML Models Built Using Clinical Parameters and Radiomic Features Extracted from 18F-Choline PET/CT for the Prediction of Biochemical Recurrence after Metastasis-Directed Therapy in Patients with Oligometastatic Prostate Cancer 178
Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis 172
Effect of vaccination with autologous tumor-loaded dendritic cells on intratumoral regulatory T cells in metastatic melanoma patients 158
Near-Complete Response to Osimertinib for Advanced Non-Small-Cell Lung Cancer in a Pretreated Patient Bearing Rare Compound Exon 20 Mutation (S768I + V774M): A Case Report 152
Prognostic value of microsatellite instability and intratumor activated cytotoxic lymphocytes in colon cancer 145
Retinoic acid inhibits the proliferative response induced by CD40 activation and interleukin-4 in mantle cell lymphoma 139
Nectin-4-Targeting Radiotracers: Novel Theranostic Agents for Precision Oncology in Cancer 138
Comparative efficacy and safety of targeted therapies for BRAF-mutant unresectable or metastatic melanoma: Results from a systematic literature review and a network meta-analysis 133
Anti-PD1 antibodies in patients aged ≥ 75 years with metastatic melanoma: A retrospective multicentre study 133
Sequencing of Ipilimumab Plus Nivolumab and Encorafenib Plus Binimetinib for Untreated BRAF-Mutated Metastatic Melanoma (SECOMBIT): A Randomized, Three-Arm, Open-Label Phase II Trial 132
Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma 126
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma 117
Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab 103
Cancer Bio-Immunotherapy in Siena": Twelfth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 9-11, 2014 103
Nivolumab plus ipilimumab in melanoma patients with asymptomatic brain metastases: 7-year outcomes and quality of life from the multicenter phase III NIBIT-M2 trial 103
Efficacy of ipilimumab plus nivolumab or ipilimumab plus fotemustine vs fotemustine in patients with melanoma metastatic to the brain: Primary analysis of the phase III NIBIT-M2 trial 102
Retrospective Chart Review of Dabrafenib Plus Trametinib in Patients with Metastatic BRAF V600-Mutant Melanoma Treated in the Individual Patient Program (DESCRIBE Italy) 102
Functional up-regulation of human leukocyte antigen class I antigens expression by 5-aza-2'-deoxycytidine in cutaneous melanoma: immunotherapeutic implications 99
Three-year follow-up of advanced melanoma patients who received ipilimumab plus fotemustine in the Italian Network for Tumor Biotherapy (NIBIT)-M1 phase II study 96
Primary Analysis and 4-Year Follow-Up of the Phase III NIBIT-M2 Trial in Melanoma Patients With Brain Metastases 95
Complementary vaccination protocol with dendritic cells pulsed with autologous tumour lysate in patients with resected stage III or IV melanoma: protocol for a phase II randomised trial (ACDC Adjuvant Trial). 94
Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial 93
Association between Helicobacter pylori infection and MALT-type lymphoma of the ocular adnexa: clinical and therapeutic implications 88
Combined and sequential expression of p53, Rb, Ras and Bcl-2 in bronchial preneoplastic lesions 86
Stability Program in Dendritic Cell Vaccines: A “Real-World” Experience in the Immuno-Gene Therapy Factory of Romagna Cancer Center 86
Efficacy and safety of ipilimumab in patients with advanced melanoma and brain metastases 84
Dendritic cell vaccination for metastatic melanoma: a 14-year monoinstitutional experience 83
Circulating memory B-cell receptor repertoire analysis identifies novel candidate antibodies against metastatic melanoma in immunotherapy-responsive patients 83
Chlamydia infection and lymphomas: Association beyond ocular adnexal lymphomas highlighted by multiple detection methods 81
Neoadjuvant plus adjuvant combined or sequenced vemurafenib, cobimetinib and atezolizumab in patients with high-risk, resectable BRAF-mutated and wild-type melanoma: NEO-TIM, a phase II randomized non-comparative study 80
Bacteria-eradicating therapy with doxycycline in ocular adnexal MALT lymphoma: A multicenter prospective trial 80
Malignant Pleural Mesothelioma: State-of-the-Art on Current Therapies and Promises for the Future 79
Italian nivolumab Expanded Access Programme in melanoma adjuvant setting: patient outcomes and safety profile 78
Association of CTLA-4 Gene Variants with Response to Therapy and Long-term Survival in Metastatic Melanoma Patients Treated with Ipilimumab: An Italian Melanoma Intergroup Study 77
First-line, Fixed-Duration Nivolumab plus Ipilimumab Followed by Nivolumab in Clinically Diverse Patient Populations With Unresectable Stage III or IV Melanoma: CheckMate 401 76
Dabrafenib-trametinib combination in 'field-practice': an Italian experience 76
CTLA-4 gene variant -1661A>G may predict the onset of endocrine adverse events in metastatic melanoma patients treated with ipilimumab 76
Activation of infiltrating cytotoxic T lymphocytes and lymphoma cell apoptotic rates in gastric MALT lymphomas - Differences between high-grade and low-grade cases 76
Radiotherapy as an immunological booster in patients with metastatic melanoma or renal cell carcinoma treated with high-dose Interleukin-2: Final data 74
First report of efficacy and safety from the phase II study SECOMBIT (SEquential COMBo Immuno and Targeted Therapy study) 72
Appropriate use of tumour biomarkers for treatment with innovative drugs: A retrospective study 72
Outcomes in patients with BRAFV600–mutated melanoma and brain metastases at baseline treated with dabrafenib plus trametinib 71
Pooled Analysis Safety Profile of Nivolumab and Ipilimumab Combination Therapy in Patients With Advanced Melanoma 71
Regression of ocular adnexal lymphoma after Chlamydia psittaci-eradicating antibiotic therapy 70
Dendritic cell-based vaccine in advanced melanoma: update of clinical outcome 70
Radiotherapy and High-Dose Interleukin-2: Clinical and Immunological Results of a Proof of Principle Study in Metastatic Melanoma and Renal Cell Carcinoma 68
Melanoma metastasis mimicking gastric cancer: a challenge that starts from diagnosis 67
ILLUMINATE 301: A randomized phase III study of tilsotolimod in combination with ipilimumab compared with ipilimumab alone in patients with advanced melanoma following progression on or after anti-PD-1 therapy 66
Correspondence re: Samowitz et al., Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. Cancer Epidemiol. Biomark. Prev., 10 : 917-923, 2001 65
High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability 61
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma 59
Low-dose temozolomide before dendritic-cell vaccination reduces (specifically) CD4(+)CD25(++)Foxp3(+) regulatory T-cells in advanced melanoma patients 57
Therapeutic efficacy of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with metastatic melanoma unresponsive to prior systemic treatments: clinical and immunological evidence from three patient cases 56
IGKV3 Proteins as Candidate "Off-the-Shelf" Vaccines for Kappa-Light Chain-Restricted B-Cell Non-Hodgkin Lymphomas 49
Adjuvant dendritic cell-based immunotherapy in melanoma: insights into immune cell dynamics and clinical evidence from a phase II trial 48
Randomized, Open-Label, Phase III Study of Tilsotolimod in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced Refractory Melanoma (ILLUMINATE-301) 48
Changes in AXL and/or MITF melanoma subpopulations in patients receiving immunotherapy 48
Radiotherapy as an immunological booster in patients with metastatic melanoma or renal cell carcinoma treated with high-dose Interleukin-2: evaluation of biomarkers of immunologic and therapeutic response 48
Melanoma vaccines in development 46
Interleukin-10 and interleukin-18 promoter polymorphisms in an Italian cohort of patients with undifferentiated carcinoma of nasopharyngeal type 42
Sequencing of Checkpoint or BRAF/MEK Inhibitors on Brain Metastases in Melanoma 41
Retinoic acid inhibits IL-6-dependent but not constitutive STAT3 activation in Epstein-Barr virus-immortalized B lymphocytes 41
Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas 39
High serum levels of soluble CD40-L in patients with undifferentiated nasopharyngeal carcinoma: pathogenic and clinical relevance 38
Tenth annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), SIENA, Italy, November 5-7, 2012 38
Isolated bone marrow manifestation of HIV-associated Hodgkin lymphoma 37
First step results from a phase II study of a dendritic cell vaccine in glioblastoma patients (CombiG-vax) 37
Retinoic acid stabilizes p27(Kip1) in EBV-immortalized lymphoblastoid B cell lines through enhanced proteasome-dependent degradation of the p45(Skp2) and Cks1 proteins 37
Genomic alterations in rectal tumors and response to neoadjuvant chemoradiotherapy: an exploratory study 36
Rituximab in patients with mucosal-associated lymphold tissue-type lymphoma of the ocular adnexa 35
Liver Metastases from Melanoma: Hepatic Intra-Arterial Chemotherapy. A Retrospective Study 35
IDIOTYPIC VACCIN 34
Ipilimumab in advanced melanoma: reports of long-lasting responses 34
Undifferentiated nasopharyngeal carcinoma from a nonendemic area: Protective role of HLA allele products presenting conserved EBV epitopes 34
Vaccination with autologous dendritic cells loaded with autologous tumor lysate or homogenate combined with immunomodulating radiotherapy and/or preleukapheresis IFN-alpha in patients with metastatic melanoma: a randomised "proof-of-principle" phase II study 31
Unexpected High Response Rate to Traditional Therapy after Dendritic Cell-Based Vaccine in Advanced Melanoma: Update of Clinical Outcome and Subgroup Analysis 31
Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma 31
Increased frequency of acute reactions to iodinated contrast media in cancer patients treated with anti-CTLA-4 immunomodulatory antibodies. 30
Diagnostic accuracy of 18F-FDG PET/CT in muscle-invasive bladder cancer: rationale and design of the MIBC-PET study 28
Infectious agents in mucosa-associated lymphoid tissue-type lymphomas: Pathogenic role and therapeutic perspectives 28
IL-17/IL-10 double-producing T cells: new link between infections, immunosuppression and acute myeloid leukemia 26
Epigenetic remodelling of DNA in cancer 25
MicroRNAs and dendritic cell-based vaccination in melanoma patients 22
Latent membrane protein 1 deletion mutants accumulate in Reed-Sternberg cells of human immunodeficiency virus-related Hodgkin's lymphoma 21
Skewing effect of sulprostone on dendritic cell maturation compared with dinoprostone 19
Totale 6.336
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.017
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 269
Totale 34.286
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202253 0 4 1 2 1 2 1 9 3 4 3 23
2022/202351 6 4 1 4 9 4 1 3 8 1 8 2
2023/2024197 3 6 3 2 0 50 0 51 0 4 19 59
2024/20251.281 38 105 69 7 189 166 31 41 192 206 133 104
2025/20264.148 269 109 272 415 526 209 451 217 417 509 408 346
2026/2027343 205 138 0 0 0 0 0 0 0 0 0 0
Totale 6.336